Stay updated on TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.

Latest updates to the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA minor version update was applied, from v3.4.1 to v3.4.2, with no changes to the displayed study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded a consolidated Locations section listing study sites across multiple regions (California, Florida, Illinois, Massachusetts, Missouri, British Columbia, Ontario, Quebec, Lombardy, Madrid). Removed the previous separate location subsections.SummaryDifference1.0%

- Check91 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no user-facing study details or content appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check98 days agoChange DetectedThe government funding status notice banner at the top of the page was removed.SummaryDifference0.3%

Stay in the know with updates to TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.